Bpifrance Files 13D/A for Constellium SE

TL;DR

Bpifrance updated its stake in Constellium SE on 6/6/24. Watch this space.

AI Summary

Bpifrance Participations SA, along with Caisse des Dépôts and EPIC Bpifrance, has amended their Schedule 13D filing regarding Constellium SE. The filing, dated June 6, 2024, indicates a change in their beneficial ownership of Constellium SE's ordinary shares. Specific details on the percentage change or new holdings are not provided in this excerpt.

Why It Matters

This filing signals a potential shift in major shareholder influence or strategy for Constellium SE, a key player in the aluminum industry.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership by significant state-backed entities can indicate strategic shifts or potential future actions affecting the company's stock.

Key Players & Entities

• Bpifrance Participations SA (company) — Filing entity
• Constellium SE (company) — Subject company
• Caisse des Dépôts (company) — Group member
• EPIC Bpifrance (company) — Group member

FAQ

Key Financial Figures

• $20.1309 — ,000 Ordinary Shares by block trades at $20.1309 per share. All of the Ordinary Shares

Filing Documents

• tm2416635d1_sc13da.htm (SC 13D/A) — 113KB
• 0001104659-24-069127.txt ( ) — 115KB

Security and Issuer

Item 1. Security and Issuer.

is hereby amended and restated as follows

Item 1 is hereby amended and restated as follows: This Amendment relates to the ordinary shares, nominal value €0.02 per share (the “Ordinary Shares”), of Constellium SE (the “Issuer”). The principal executive offices of the Issuer are located at Washington Plaza, 40-44 rue Washington, 75008 Paris, France.

Identity and Background

Item 2. Identity and Background.

is hereby amended and supplemented as follows

Item 2 is hereby amended and supplemented as follows: As of the date hereof, Bpifrance Participations directly holds 12,593,903 Ordinary Shares. As of the date hereof, neither Bpifrance S.A., CDC nor EPIC holds any Ordinary Shares directly. Bpifrance S.A. may be deemed to be the beneficial owner of 12,593,903 Ordinary Shares, indirectly through its sole ownership of Bpifrance Participations. CDC and EPIC may be deemed to be the beneficial owners of 12,593,903 Ordinary Shares, indirectly through their joint ownership and control of Bpifrance S.A. Attached as Appendices A, B, C and D to Item 2 is information concerning the executive officers and directors of Bpifrance Participations, Bpifrance S.A., CDC and EPIC respectively, required to be disclosed in response to Item 2 and General Instruction C to Schedule 13D. None of the Reporting Persons, nor, to the best of their knowledge, any of the persons referred to in Appendices A, B, C and D to Item 2 has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.

Purpose of Transaction

Item 4. Purpose of Transaction.

is hereby amended and supplemented

Item 4 is hereby amended and supplemented as follows: On June 5, 2024, Bpifrance Participations sold 3,800,000 Ordinary Shares by block trades at $20.1309 per share. All of the Ordinary Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Ordinary Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Ordinary Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. In addition, the Reporting Persons may continue to acquire additional Ordinary Shares of the Issuer on the open market, if conditions are favorable, but are under no obligation to do so. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein. 6 Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer.

is hereby amended and supplemented as follows

Item 5 is hereby amended and supplemented as follows: As of the date hereof, Bpifrance Participations holds directly 12,593,903 Ordinary Shares, which represents approximately 8.6% of the Issuer’s Ordinary Shares. As of the date hereof, none of Bpifrance S.A., CDC or EPIC holds any Ordinary Shares directly. Bpifrance S.A. may be deemed to be the beneficial owner of 12,593,903 Ordinary Shares, indirectly through its sole ownership of Bpifrance Participations. CDC and EPIC may be deemed to be the beneficial owners of 12,593,903 Ordinary Shares, indirectly through their joint ownership and control of Bpifrance S.A. (a) See also the information contained on the cover pages of this Amendment, which is incorporated herein by reference. The percentage of Ordinary Shares beneficially owned by each Reporting Person is based on 145,832,473 outstanding Ordinary Shares of the Issuer, as reported in the Issuer’s Form 6-K filed with the SEC on May 14, 2024. (b) See the information contained on the cover pages of this Amendment, which is incorporated herein by reference. (c) Other than as described in Item 4 above, there have been no reportable transactions with respect to the Ordinary Shares of the Issuer within the last 60 days by the Reporting Persons, or, to the best of their knowledge, any of the persons referred to in Appendices A, B, C and D to Item 2. (d) Not applicable. (e) Not applicable.

Material to Be Filed as Exhibits

Item 7. Material to Be Filed as Exhibits. Exhibit 1: Power of Attorney — CDC (incorporated by reference to Exhibit 1 to Amendment No. 2 to the Schedule 13D filed by Bpifrance Participations on September 7, 2017). Exhibit 2: Power of Attorney — Bpifrance S.A (incorporated by reference to Exhibit 2 to Amendment No. 2 to the Schedule 13D filed by Bpifrance Participations on September 7, 2017). Exhibit 3: Power of Attorney — EPIC and Bpifrance Participations (incorporated by reference to Exhibit 3 to Amendment No. 1 to the Schedule 13G filed by Bpifrance Participations on February 14, 2017). 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: June 6, 2024 Caisse des dépôts ET CONSIGNATIONS By: /s/ Laurence Giraudon Name: Laurence Giraudon Title: Chief Operating Officer, Finance and Operations Department, Asset Management Division Bpifrance Participations S.A. By: /s/ Sophie Paquin Name: Sophie Paquin Title: Director of Legal Affairs Bpifrance S.A. By: /s/ Boubakar Dione Name: Boubakar Dione Title: Group Director of Legal Affairs EPIC Bpifrance By: /s/ Sophie Paquin Name: Sophie Paquin Title: Director of Legal Affairs 8 APPENDIX A Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of BPIFRANCE PARTICIPATIONS S.A. The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Participations S.A. are set forth below. The business address of each director and executive officer is Bpifrance Participations S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France. BOARD OF DIRECTORS Nam

View Full Filing

View this SC 13D/A filing on SEC EDGAR